Pharvaris N.V.
General ticker "PHVS" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.0B (TTM average)
Pharvaris N.V. follows the US Stock Market performance with the rate: 53.2%.
Estimated limits based on current volatility of 6.1%: low 25.84$, high 29.18$
Factors to consider:
- Total employees count: 14 as of 2020
- Current price 20.9% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [9.13$, 22.90$]
- 2025-12-31 to 2026-12-31 estimated range: [6.49$, 16.76$]
Financial Metrics affecting the PHVS estimates:
- Negative: with PPE of -6.1 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.12 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PHVS quotes
Long-term PHVS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €0.00MM | €0.00MM | €0.00MM |
| Operating Expenses | €86.71MM | €96.91MM | €145.69MM |
| Operating Income | €-86.71MM | €-96.91MM | €-145.69MM |
| Non-Operating Income | €11.06MM | €-2.91MM | €13.29MM |
| Interest Expense | €0.02MM | €0.00MM | €0.00MM |
| R&D Expense | €57.38MM | €65.58MM | €98.56MM |
| Income(Loss) | €-75.65MM | €-99.83MM | €-132.40MM |
| Taxes | €0.00MM | €0.00MM | €1.83MM |
| Profit(Loss)* | €-76.33MM | €-100.88MM | €-134.22MM |
| Stockholders Equity | €149.26MM | €384.05MM | €267.76MM |
| Inventory | €4.04MM | €0.00MM | €0.00MM |
| Assets | €167.73MM | €398.69MM | €291.37MM |
| Operating Cash Flow | €-67.16MM | €-93.05MM | €-120.13MM |
| Capital expenditure | €0.12MM | €0.09MM | €0.54MM |
| Investing Cash Flow | €-0.12MM | €-0.09MM | €-0.54MM |
| Financing Cash Flow | €8.65MM | €325.39MM | €2.68MM |
| Earnings Per Share** | €-2.27 | €-2.63 | €-2.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.